Tag: Alzheimer’s
Early-Stage Alzheimer Disease Has Adverse Financial Consequences
Robust evidence shows households are at significant risk for large adverse changes in liquid assets
New Alzheimer Disease Drug to Be Submitted for FDA Approval
New analysis of study results suggests highest dose of aducanumab may help slow cognitive decline
Long Sleep Duration Linked to Cognitive Decline in Hispanics
Long sleep duration predicts seven-year cognitive decline in U.S. Hispanics/Latinos
Sex-Specific Criteria May Up Accuracy for Diagnosis of aMCI
Non-sex-specific criteria less accurate for diagnosis of amnestic mild cognitive impairment
Exercise May Slow Brain Deterioration in Alzheimer Disease
Findings did not differ between aerobic exercise and stretching and toning
Migraines Linked to Higher Risk for Dementia, Alzheimer Disease
However, no link seen between migraines and vascular dementia
Cerebrovascular Risk Factors May Up Risk for Parkinson Disease
Most cerebrovascular risk factors linked to higher risk for subsequent diagnosis of Parkinson disease
Plasma Assay Promising for Diagnosis of Early Alzheimer Disease
Aβ42/Aβ40, age, and APOE ε4 status combination corresponds with amyloid PET with AUC of 0.94
Novel PET Staging System May Help Monitor Alzheimer Disease
Positron emission tomography used to track stages of β-amyloid accumulation in vivo
Physical Activity Linked to Slower Aβ-Related Cognitive Decline
Exercise, lower vascular risk independently attenuate negative link for Aβ burden, cognitive decline
